Scleroderma Panel
The Scleroderma Panel test detects specific autoantibodies to help diagnose and evaluate scleroderma and related autoimmune disorders.
The Scleroderma Panel is a group of blood tests designed to detect autoantibodies associated with scleroderma (systemic sclerosis), a chronic autoimmune disease that affects the skin and internal organs.
This panel may include antibodies such as anti-centromere, anti-Scl-70 (topoisomerase I), anti-RNA polymerase III, and others. The presence and pattern of these antibodies help in diagnosing the condition, assessing disease subtype, and predicting disease progression.
Scleroderma can cause skin thickening, joint pain, and involvement of organs like the lungs, heart, and kidneys. Early detection through antibody testing helps in timely management and monitoring.
Test Recommended For
- Individuals with skin thickening or hardening
- Patients with symptoms of autoimmune disease
- People with Raynaud’s phenomenon
- Individuals with suspected scleroderma
- Patients advised for autoimmune panel testing